NCT06291116: Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease
- State
- Under way
- Phase
- Phase 2
- People
- 120 planned
- Started
- 12 May 2026
- Primary completion
- 1 Jul 2030
- Arms
- experimental
- Results
- None posted
- 4 Mar 2024: Trial registered
- 12 May 2026: Trial started